SER
Serina Therapeutics Inc
2.10$
-2.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -1,403.3% | – | – | – | – | – | – | – | – | – | – | |
| – | -88.9% | +316.7% | +128.0% | -1.8% | +0.0% | -69.6% | -5.9% | +6.3% | +41.2% | -25.0% | +0.0% | – | |
| – | – | +0.0% | +764.2% | +139.3% | -9.9% | -3.2% | -6.9% | +12.2% | -5.1% | +13.6% | -2.4% | – | |
| – | – | – | -994.4% | – | -115.6% | – | +55.2% | +97.7% | -177.9% | – | -346.9% | – | |
| – | -41.2% | -80.0% | -100.0% | – | +66.7% | -100.0% | – | -71.7% | +353.8% | -57.6% | +12.0% | – | |
| – | -41.2% | -80.0% | – | – | +66.7% | -100.0% | – | -71.7% | +353.8% | -57.6% | +12.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +96.9% | -50.8% | +113.3% | +14.6% | +4.0% | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | – | – | |
| – | -750.0% | – | +96.7% | -98.4% | +5,750.0% | -2.3% | +13.3% | +15.7% | -92.5% | +5,317.3% | -80.0% | – | |
| – | +5,210.3% | -84.3% | -332.4% | – | – | +36.2% | +198.2% | +45.4% | -315.7% | – | -107.0% | – | |
| – | – | -3,219.6% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.